ILIAD Biotechnologies
Pre-clinicalILiAD Biotechnologies is a clinical stage biotechnology company dedicated to the prevention and treatment of diseases caused by Bordetella Pertussis. Our lead candidate, BPZE1, represents the most advanced next generation pertussis vaccine, successfully completing two Phase 2 clinical trials. Join us in advancing public health through innovative vaccine solutions.
About
ILiAD Biotechnologies is a clinical stage biotechnology company dedicated to the prevention and treatment of diseases caused by Bordetella Pertussis. Our lead candidate, BPZE1, represents the most advanced next generation pertussis vaccine, successfully completing two Phase 2 clinical trials. Join us in advancing public health through innovative vaccine solutions.
Funding History
2Total raised: $12.2M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile